Adi F Gazdar

发表

Differential Inactivation of Caspase-8 in Lung Cancers

John D Minna, J. Minna, A. Gazdar, 2002, Cancer biology & therapy.

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.

Luc Girard, John D Minna, J. Minna, 2016, Cell reports.

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

Joachim Herz, John D Minna, J. Minna, 2004, Trends in molecular medicine.

Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ

Annette McWilliams, Katrien Grunberg, Stephen Lam, 2009, Clinical Cancer Research.

Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Yang Xie, John K Field, Luc Girard, 2008, Cancer research.

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.

Alexander Pertsemlidis, Ignacio I Wistuba, John D Minna, 2015, Cancer research.

Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.

Luc Girard, Maria P Wong, John D Minna, 2007, Cancer research.

Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers

Arvind Virmani, John D Minna, Jack A Roth, 2003, International journal of cancer.

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

Carlos L Arteaga, Frederick Y. Wu, A. Gazdar, 2006, Cancer cell.

Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.

Xudong Dai, Chenchen Yang, Muneesh Tewari, 2015, Cancer research.

Predictive and prognostic factors for non-small cell lung cancer--potholes in the road to the promised land.

Adi F Gazdar, Joan H Schiller, 2011, Journal of the National Cancer Institute.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

Elisa Rossi, Vienna Ludovini, Lucio Crino, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

Jaime Rodriguez-Canales, Yang Xie, Luc Girard, 2016, Clinical Cancer Research.

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

B Nebiyou Bekele, A. Gazdar, H. Shigematsu, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells.

Kenya Yoshida, Mitsuo Sato, Tetsunari Hase, 2010, Cancer letters.

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Humam Kadara, Diane D. Liu, Diane D Liu, 2011, Clinical Cancer Research.

DNA methylation data analysis and its application to cancer research.

Michael Q. Zhang, Xiaotu Ma, Michael Q Zhang, 2013, Epigenomics.

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Tao Wang, Yang Xie, Chunli Shao, 2014, Proceedings of the National Academy of Sciences.

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

A. Gazdar, H. Shigematsu, Adi F Gazdar, 2006, International journal of cancer.

Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small‐cell lung cancer cell lines

Calum MacAulay, Luc Girard, Stephen Lam, 2006, Genes, chromosomes & cancer.

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs

Alexander Pertsemlidis, Luc Girard, John D Minna, 2010, Journal of experimental & clinical cancer research : CR.

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Charles F Timmons, John D Minna, 2002, Oncogene.

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers

Michael Q. Zhang, Yang Xie, Xiaotu Ma, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Kwon-Sik Park, Vitor M Faça, Christopher J Kemp, 2011, Cancer cell.

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Luc Girard, Suzie K. Hight, Dhruba Deb, 2016, The Journal of clinical investigation.

Memorial Sloan-Kettering Cancer

Ziding Feng, Antonio Marchetti, Harubumi Kato, 2006 .

High‐resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines

Bradley P. Coe, Calum Macaulay, Cathie Garnis, 2005, Genes, chromosomes & cancer.

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

John D Minna, J. Minna, S. Toyooka, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

Luc Girard, John D Minna, D. Fishman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lung cancer cell lines as tools for biomedical discovery and research.

Luc Girard, John D Minna, W. Lam, 2010, Journal of the National Cancer Institute.

Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions

Calum MacAulay, Annette McWilliams, Stephen Lam, 2002, Oncogene.

The TP53 gene, tobacco exposure, and lung cancer

Toshihide Tsuda, S. Toyooka, A. Gazdar, 2003, Human mutation.